2026 Q2 Portfolio Activity
In 2026 Q2, EQT Fund Management S.a r.l. maintained a portfolio of 5 distinct positions. They heavily accumulated shares in EVOMMUNE INC, increasing the position by 7.3%.
Position History
hover any row below to update
Loading…
Total Positions
5
Quarter
2026 Q2
Top Holding
WAY (59.2%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-5 of 5
EQT Fund Management S.a r.l. Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
WAY
WAYSTAR HLDG CO...
|
Healthcare | 59.21% | 58.77% |
#1
Prev: #1
|
7.0 |
—
|
no change | no change |
P
S
|
24,879,437 | $510,774,842 |
$37.92
-34.7%
|
2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-13 | ||
|
PHVS
PHARVARIS N V
|
Healthcare | 13.73% | 9.48% |
#2
2
Prev: #4
|
6.5 |
—
|
no change | no change |
P
S
|
3,424,609 | $118,422,979 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
OCS
OCULIS HOLDING ...
|
Healthcare | 11.18% | 15.37% |
#3
1
Prev: #2
|
7.0 |
—
|
1,050,000 | 17.8% |
P
S
|
6,950,294 | $96,400,578 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
EVMN
EVOMMUNE INC
|
Healthcare | 8.15% | 11.10% |
#4
1
Prev: #3
|
5.8 |
—
|
358,680 | 7.3% |
P
S
|
5,288,313 | $70,281,680 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
N/A
AGOMAB THERAPEU...
|
|
Unknown | 7.74% | 5.28% |
#5
Prev: #5
|
4.6 |
—
|
no change | no change |
P
S
|
5,141,992 | $66,743,056 | — | 13F Filing | 2026-06-30 | 2026-08-13 |
Showing 1-5 of 5 holdings